Kobayashi Pharmaceutical Co (KOY) fair value: what the stock is really worth
As of Nov 17, 2026: fair value (intrinsic value) of Kobayashi Pharmaceutical Co stock €29.87, price €40.03, that is 25.4% below the price, quality 58 out of 100. Rating: overvalued. Calculated from audited financials with 24 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Kobayashi Pharmaceutical Co
KOY · FExpensive (fair value 25% below the price), but solid company and rising price: meets 2 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 16, 2026.
How to read this chart
60‑month range €27.38 – €75.71 · fair‑value band €23.97 – €39.23 · the €40.03 price screens above the €29.87 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 16, 2026.
Every Wednesday you see whether Kobayashi Pharmaceutical Co is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, Southeast Asia, and internationally.
Show moreShow less
The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese herbal medicine that promotes the breakdown and metabolism of fat; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling gel sheet; and deodorizing air fresheners, lens cleaners, and oral hygiene products.
It also manufactures and sells pharmaceuticals, fragrances, deodorants, cosmetics, health food, synthetic resin processed products, paper products, and hand warmers; and sells daily necessities.
In addition, the company engages in transportation, real estate management, advertising planning and production, sales promotion and market research, promotional goods production and sales, and asset management activities, as well as in pharmacy, retail, and cleaning industries.
Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.
Stock analysis
Kobayashi Pharmaceutical Co (KOY) currently trades at €40.03, while our model-based Fair Value estimate is €29.87, 25% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of €21.96 per share, and 1 of the 24 models we run sit above the €40.03 price.
Bear case: the Growth Earnings group reads lowest at €4.46, and 23 of the 24 models stay below the price. Data coverage for this calculation is medium.
Scenario range: €23.97 (bear) to €39.23 (bull), the price of €40.03 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 58/100 (solid quality), in the Consumer Defensive sector.
Weak Growth: Revenue growth is weak: less than 2 % a year.
Kobayashi Pharmaceutical Co reported revenue of ¥166B in FY2025 versus ¥155B in FY2021, a compound +1.6%/yr. Reported net income was ¥3.7B in FY2025, compounding −34.4%/yr from FY2021.
Key figures
Market cap €3.0B Mid · P/E ratio 117.7 · P/S ratio 2.60 · EPS (TTM) €0.3400 · Dividend yield 1.5% · Net margin 2.2% · Return on equity 2.2% · Return on assets (EBIT) 9.0% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 28 out of 100 (low confidence).
What moves the price
The share trades about 1% below its 52-week high and 49% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Consumer Defensive peers we cover trades at −33% fair-value upside, at −25%, KOY screens cheaper than that median.
Fair Value models
All 24 models by family
The fair value above starts from this blend and is adjusted for a year distorted by one-off effects.
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
KOY screens overvalued: fair value 25% below the price. Compare with Colgate-Palmolive Company →
Compare Kobayashi Pharmaceutical Co with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Household & Personal Products · 241 stocks
Valuation Multiplesvs Household & Personal Products median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Consumer Staples sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- EBIT margin by industry
- P/S ratio by industry
- Piotroski F-Score screener with fair value
- Undervalued stocks: German Stocks
- Valuation of the Germany market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Godrej Consumer Products Limited GODREJCP | ₹892.70 | ₹1,146 | +28% | vs KOY |
| Puig Brands, S.A PUIG | €20.44 | €24.28 | +19% | vs KOY |
| Henkel AG HEN | €79.50 | €83.75 | +5% | vs KOY |
| Beiersdorf Aktiengesellschaft, BEI | €83.46 | €69.09 | −17% | vs KOY |
| The Clorox Company CLX | $110.17 | $74.29 | −33% | vs KOY |
| Church & Dwight Co CHD | $114.74 | $65.04 | −43% | vs KOY |
| Colgate-Palmolive Company CL | $100.99 | $56.16 | −44% | vs KOY |
| Marico Limited MARICO | ₹913.65 | ₹493.84 | −46% | vs KOY |
| The Estée Lauder Companies Inc EL | $108.61 | $44.21 | −59% | vs KOY |
| Hindustan Unilever Limited HINDUNILVR | ₹2,000 | ₹775.25 | −61% | vs KOY |
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Kobayashi Pharmaceutical Co (KOY) overvalued or undervalued?
What is the fair value of KOY?
What is the quality score of KOY?
What is the price target for Kobayashi Pharmaceutical Co (KOY)?
What is the Kobayashi Pharmaceutical Co stock forecast for 2026?
What is the revenue of Kobayashi Pharmaceutical Co (KOY)?
Does Kobayashi Pharmaceutical Co pay a dividend?
How much is the dividend of Kobayashi Pharmaceutical Co (KOY) and when is the ex-dividend date?
What growth is priced into Kobayashi Pharmaceutical Co (KOY)?
What discount rate (WACC) does the fair value of KOY use?
What is a reverse DCF?
How much growth has Kobayashi Pharmaceutical Co (KOY) delivered so far?
How fast is the sector of Kobayashi Pharmaceutical Co (KOY) growing?
What is the free cash flow yield of Kobayashi Pharmaceutical Co (KOY)?
What is the intrinsic value of Kobayashi Pharmaceutical Co (KOY)?
Is Kobayashi Pharmaceutical Co stock overvalued or undervalued in 2026?
Is fair value the same as the market price of KOY?
How much is Kobayashi Pharmaceutical Co worth?
What do the bullish and bearish scenarios say about KOY?
What is the P/E ratio of KOY?
What is the PEG ratio of KOY?
How solid is the balance sheet of Kobayashi Pharmaceutical Co (KOY)?
How far is KOY from its 52-week high?
Which stocks are comparable to Kobayashi Pharmaceutical Co?
Is Kobayashi Pharmaceutical Co stock attractive at the current price?
How is the fair value of KOY calculated?
Is it still worth investing in stocks now?
What is the share price of Kobayashi Pharmaceutical Co (KOY)?
What should I pay attention to with Kobayashi Pharmaceutical Co right now?
Key figures of Kobayashi Pharmaceutical Co
How large is the market capitalisation of Kobayashi Pharmaceutical Co (KOY)?
What is the P/S ratio of Kobayashi Pharmaceutical Co (KOY)?
What are the earnings per share of Kobayashi Pharmaceutical Co (KOY)?
What is the dividend yield of Kobayashi Pharmaceutical Co (KOY)?
What is the net margin of Kobayashi Pharmaceutical Co (KOY)?
What is the return on equity of Kobayashi Pharmaceutical Co (KOY)?
What is the EBIT return on assets of Kobayashi Pharmaceutical Co (KOY)?
What is the operating margin of Kobayashi Pharmaceutical Co (KOY)?
How fast is revenue growing at Kobayashi Pharmaceutical Co (KOY)?
How fast are earnings growing at Kobayashi Pharmaceutical Co (KOY)?
Watch Kobayashi Pharmaceutical Co in the live analysis
One click puts Kobayashi Pharmaceutical Co on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.